Abstract
Surgical site infection (SSI) frequently occurs after reconstructive mammaplasty for breast cancer using tissue expander and cohesive silicone gel implant techniques. This retrospective analysis found that silicone gel implants were the cause of SSI associated with reconstructive mammaplasty. In addition, experience with postoperative docetaxel cyclophosphamide (TC) chemotherapy, a standard method after surgery for breast cancer, found that SSI is apparently frequently associated with silicone gel implants. Review of the procedures intended to reduce the occurrence of SSI associated with silicone gel implants resulted in great reduction in SSI. Review of the procedures emphasized the importance of clear understanding of the surgical plan by both theater nurses and surgeons.
